Research, trials, devices, and safety notices — labeled by evidence strength so you can tell solid science from hype.
Pulled from official registries and public research sources, then labeled by evidence strength before publication.
Saved on this device only. Matching items rise on Today. No health profile required.
33 items from 4 live sources. Updated Jul 28, 2026, 3:17 AM GMT-5.
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis... Action: On 5/27/2026, field safety notices were emailed to customers who were asked to do the following: 1) Update insulin pump software...
RECRUITING, NA. Interventions: Omnipod 5 System, Omnipod 6 System. Locations: Los Angeles, California, United States | Santa Barbara, California, United States | Aurora, Colorado, United States. This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glycemia.
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC. Lot 1725204004 were designated for destruction because the G7 sensors were not properly sterilized and have an increased risk of skin infection if used. Lot 1725... Action: On 05/26-27/2026, the firm issued a Press Release and sent an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" informing custome...
RECRUITING. Locations: Aurora, Colorado, United States. This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.
RECRUITING, NA. Interventions: TranS-C Intervention Arm, Attention Control Enhanced Usual Care (EUC) Arm. Locations: Atlanta, Georgia, United States | Atlanta, Georgia, United States. This study aims to learn whether a cognitive behavioral intervention can improve lifestyle and glucose targets for adults with type 1 diabetes.
A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the foreground, causing the Glucose Compass to flicker through previous EG... Action: On 04/14/2026, the firm sent via the iOS App an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" communication informing custome...
A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the foreground, causing the Glucose Compass to flicker through previous EG... Action: On 04/14/2026, the firm sent via the iOS App an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" communication informing custome...
A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the foreground, causing the Glucose Compass to flicker through previous EG... Action: On 04/14/2026, the firm sent via the iOS App an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" communication informing custome...
Daily briefings, device safety watches, trial roundups, and research notes — each linked back to original sources.
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
Diabetes In Control
Scientists have identified a protein that enhances how the body uses insulin, and early lab work suggests a small peptide derived from it may help improve blood sugar control in Type 1 diabetes.
BioSpace
Multiple therapies in development are advancing toward the goal of reducing or eliminating insulin dependence for people with Type 1 diabetes. Researchers describe the current state of the pipeline as making 'remarkable progress.'
Medical Xpress
A preclinical study suggests that using multiple strategies together may help slow the advancement of type 1 diabetes. While early-stage research, the findings point to a promising direction for future development.
Breakthrough T1D
Sana Biotechnology's research shows that gene-modified pancreatic cells remain functional and continue making insulin over time. The findings represent progress in exploring whether edited cells could one day help people with Type 1 diabetes.
New Shorts daily on YouTube and TikTok
CGM Users Move More: What a New Study Reveals About Glucose Monitoring and Physical Activity
CGM users with Type 1 move more than people checking fingersticks.
Diluted Insulin in Automated Systems May Reduce Dangerous Lows in Very Young Children
Automated insulin pumps work differently for babies and toddlers.
Understanding Autoimmune Disease Risk in Children With Type 1 Diabetes
Nearly 1 in 5 kids with type 1 diabetes develop a second autoimmune condition.
Beyond A1C: Understanding the Growing Toolkit of Glucose Metrics
Your CGM shows way more than your A1C ever could.
What Teens and Parents Really Worry About Living with Type 1 Diabetes
Teens with Type 1 diabetes carry more stress than their parents realize.
Could Respiratory Infections During Pregnancy and Infancy Play a Role in Type 1 Diabetes?
Researchers linked respiratory infections in pregnancy to type 1 diabetes risk.
How Epigenetic Changes May Fuel Type 1 Diabetes
DNA isn't just your genes — chemical tags on it may trigger type 1.
What Makes Some People With Type 1 Diabetes Healthier Than Expected? A New Study Raises Important Questions
Some people with Type 1 diabetes stay heart-healthy despite the odds.
Updated daily from ClinicalTrials.gov
Showing 6 of 8 programs tracked
Track all 8programs →624 evidence-labeled articles across 6 topics
From early detection through autoantibody screening to innovative device technology and immunomodulatory treatments, the…
Read →Living With T1DA new 8-week study of the twiist AID system in 19 adults with Type 1 diabetes found that participants spent about 70% of…
Read →Eating & NutritionA new study found that among lifestyle factors, sleep quality had the strongest link to how people with Type 1 diabetes…
Read →Diagnosis & Early DetectionA study of pediatric DKA cases during Ramadan reveals that fasting, sleep changes, and dehydration create specific patte…
Read →Causes & What We KnowScientists are using artificial intelligence to identify which pancreatic cells stop working properly in type 2 diabetes…
Read →LifestyleA new study finds that people using automated insulin delivery systems report both improved glycemic outcomes and reduce…
Read →Chapter 5 — Age 17
“Closing in on seventeen, here's the short version of everything the younger me needed to hear.”
Closing in on seventeen, here's the short version of everything the younger me needed to hear.
Brooke's chapters are personal lived experience shared to make people feel less alone. They are not medical advice and do not describe a treatment plan. Talk to your own care team about your numbers, devices, and decisions.
If FDA, MedWatch, or a manufacturer issues a relevant CGM, pump, app, insulin, or glucagon alert, it should bypass the normal feed and hit the family alert lane first.
Medtronic MiniMed, Inc.
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
Open alertMedtronic MiniMed, Inc.
A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis... Action: On 5/27/2026, field safety notices were emailed to customers who were asked to do the following: 1) Update insulin pump software...
Open alertFDA device recall
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Open alertFDA device recall
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Open alert